medigraphic.com

2018, Number 4

<< Back Next >>

Rev Clin Esc Med 2018; 8 (4)

Análisis de la situación epidemiológica y manejo actual de los sarcomas de tejido blando y hueso en el Hospital México, San José Costa Rica

Rojas-Vigott R, Landaverde DU, Ramos-Esquivel A

Language: Spanish
References: 5
Page: 1-5
PDF size: 369.14 Kb.


ABSTRACT

Background: Soft tissue sarcomas, and bone sarcomas, are rare neoplasm. These malignancies are more likely to be presented in young adults. There are several subtypes which must be treated individually. This is a current analysis of the epidemiological situation and also the management of sarcomas at the Unit of Sarcomas at Mexico Hospital in Costa Rica.
Methods: The unif of Sarcomas data base was evaluated from February 2012 to December 2017, a total of 60 registries were analyzed. Descriptive statistics were used.
Results: 70% of all sarcomas are analyzed in the multidisciplinary tumor board. Soft tissues sarcomas are more common (65.6%) in comparison with bone sarcomas. Sarcomas in general are predominantly more frequent in males (56%). 75.4% of all sarcomas come to our clinic in early stage and will receive curative intended treatment.
Conclusion: Although there are clear improvements in the multidisciplinary management approach in the Unit of Sarcomas at Mexico Hospital, even more institutional efforts are needed to optimize the timing from diagnosis to treatment in patients with sarcoma.


REFERENCES

  1. SEER. Cancer Statistics Fact Sheets: Bone and Joint Cancer. Bethesda, MD: National Cancer Institute, 2014.

  2. Siegel GW Biermann JS Lucas D. et al. The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework. J Multidiscip Health. 2015; 109: 15.

  3. Hussein R Smith MA. Soft tissue sarcomas: are current referral guidelines. sufficient? Ann R Coll Surg Engl. 2005; 87: 171–173.

  4. National Comprehensive Cancer Network. Soft Tissue Sarcoma. 2018 ; (1) : 1-82.

  5. Gronchi A Ferrari S Quagliuolo V. et al. Full-dose neoadjuvant anthracycline + ifosfamide chemotherapy is associated with a relapse free survival (RFS) and overall survival (OS) benefit in localized high-risk adult soft tissue sarcomas (STS) of the extremities and trunk wall: interim analysis of a prospective randomized trial. Ann. Oncol. 2016; 27 (6):1-36.




2020     |     www.medigraphic.com